Skip to main content

Toxicities Rare After Two Weeks of CAR T-Cell Therapy Infusion

Medically reviewed by Carmen Pope, BPharm. Last updated on July 30, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, July 30, 2024 -- New-onset cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are rare beyond two weeks following infusion of CD19-directed chimeric antigen receptor T (CAR T)-cell therapies, according to a study published online July 23 in Blood Advances.

Noting that the U.S. Food and Drug Administration has mandated that patients should remain close to treatment centers for four weeks to monitor and manage toxicity risks associated with CD19-directed CAR T-cell therapies, including CRS and ICANS, Nausheen Ahmed, M.D., from the University of Kansas Medical Center in Westwood, and colleagues conducted a retrospective cohort study involving 475 patients infused with axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel from 2018 to 2023 to assess onset and duration of CRS and ICANS.

The researchers found that although there were differences in the incidence and duration of CRS and ICANS between CAR T-cell products, new-onset CRS and ICANS were extremely rare after two weeks following infusion, occurring in 0 and 0.7 percent, respectively. After two weeks, there were no new cases of CRS, while a single case of new-onset ICANS occurred in the third week following infusion. In the early follow-up period, nonrelapse mortality was driven by ICANS (1.1 percent until day 28), followed by infection through three months postinfusion (1.2 percent).

"These data support further investigation into individualized monitoring strategies for stable patients," the authors write. "A flexible monitoring period may help to decrease financial and geographic limitations for patients and make CAR T more accessible and feasible."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2024

Read this next

20-Minute Mindful Breathing Intervention Reduces Cancer Pain

THURSDAY, Aug. 22, 2024 -- A single session of 20-minute mindful breathing is beneficial for reducing cancer pain, according to a study published online Aug. 20 in BMJ Supportive...

Even Low-Risk Alcohol Consumption Ups Mortality Risk in Older Adults

WEDNESDAY, Aug. 21, 2024 -- Even low-risk drinking is associated with higher mortality among older adults, according to a study published online Aug. 12 in JAMA Network...

Suicide Attempt, Death Up for Spouses of Patients With Cancer

TUESDAY, Aug. 20, 2024 -- Spouses of patients with cancer have an increased risk for suicide attempt and suicide death, especially during the first year after diagnosis, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.